{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:29:33Z","timestamp":1761611373898},"reference-count":11,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":57,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1002\/jcph.532","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T19:42:48Z","timestamp":1436211768000},"page":"875-887","source":"Crossref","is-referenced-by-count":13,"title":["Reporting guidelines for population pharmacokinetic analyses"],"prefix":"10.1002","volume":"55","author":[{"given":"Kevin","family":"Dykstra","sequence":"first","affiliation":[{"name":"qPharmetra LLC; Andover MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Mehrotra","sequence":"additional","affiliation":[{"name":"Division of Pharmacometrics; US Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoffer Wenzel","family":"Torn\u00f8e","sequence":"additional","affiliation":[{"name":"Clinical Reporting; Novo Nordisk; Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Kastrissios","sequence":"additional","affiliation":[{"name":"Pharsight Consulting Services; Certara; St. Louis MO USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bela","family":"Patel","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology; Quantitative Sciences; GlaxoSmithKline; King of Prussia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidal","family":"Al-Huniti","sequence":"additional","affiliation":[{"name":"Quantitative Clinical Pharmacology; AstraZeneca; Waltham MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravin","family":"Jadhav","sequence":"additional","affiliation":[{"name":"Quantitative Pharmacology and Pharmacometrics; Merck and Co.; Whitehouse Station NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaning","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Pharmacometrics; US Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonkyung","family":"Byon","sequence":"additional","affiliation":[{"name":"Global Innovative Pharma Business Clinical Pharmacology; Pfizer Inc.; Groton CT USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,7,6]]},"reference":[{"key":"10.1002\/jcph.532-BIB0001|jcph532-cit-0001","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF01060053","article-title":"Evaluation of methods for estimating population pharmacokinetic parameters I. Michaelis-menten model: routine clinical pharmacokinetic data","volume":"1980","author":"Sheiner","year":"1980","journal-title":"J Pharmacokin Biopharm."},{"key":"10.1002\/jcph.532-BIB0002|jcph532-cit-0002","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1177\/0091270010377788","article-title":"Pharmacometrics as a discipline is entering the \u201cindustrialization\u201d phase: standards, automation, knowledge sharing, and training are critical for future success","volume":"50","author":"Romero","year":"2010","journal-title":"J Clin Pharmacol."},{"key":"10.1002\/jcph.532-BIB0003|jcph532-cit-0003","unstructured":"http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/U"},{"issue":"2","key":"10.1002\/jcph.532-BIB0004|jcph532-cit-0004","doi-asserted-by":"crossref","first-page":"E456","DOI":"10.1208\/aapsj070245","article-title":"A guide for reporting the results of population pharmacokinetic analyses: a Swedish perspective","volume":"7","author":"Wade","year":"2005","journal-title":"AAPS J"},{"key":"10.1002\/jcph.532-BIB0005|jcph532-cit-0005","unstructured":"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/"},{"issue":"(e51)","key":"10.1002\/jcph.532-BIB0006|jcph532-cit-0006","first-page":"1","article-title":"Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance","volume":"2","author":"Byon","year":"2013","journal-title":"CPT:PSP"},{"issue":"4","key":"10.1002\/jcph.532-BIB0007|jcph532-cit-0007","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1208\/s12248-012-9387-9","article-title":"Guidelines for the quality control of population pharmacokinetic-pharmacodynamic analyses: an industry perspective","volume":"14","author":"Bonate","year":"2012","journal-title":"AAPS J"},{"key":"10.1002\/jcph.532-BIB0008|jcph532-cit-0008","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40262-013-0114-1","article-title":"Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspective","volume":"53","author":"Jamesen","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jcph.532-BIB0009|jcph532-cit-0009","unstructured":"Karlsson MO Holford N. http:\/\/www.page-meeting.org\/default.asp?abstract=1434"},{"key":"10.1002\/jcph.532-BIB0010|jcph532-cit-0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","article-title":"Ways to fit a PK model with some data below the quantification limit","volume":"28","author":"Beal","year":"2001","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1002\/jcph.532-BIB0011|jcph532-cit-0011","unstructured":"http:\/\/www.fda.gov\/AboutFDA\/CentersOffices\/OfficeofMedicalProductsandTobacco\/CDER\/ucm167032.htm"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.532","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jcph.532\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T13:04:43Z","timestamp":1657803883000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,6]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.532","relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7,6]]}}}